FDA Approves Apixaban Generics
The US FDA has announced the approval of 2 applications for apixaban—marking the first generic approval of a direct oral anticoagulant.
Related Articles
1/4 of Pediatric Liver Transplant Recipients Experience Early Hospital Readmission
Factors associated with 30-day readmission were shorter hospital stays after transplant, insurance status, and patient history of diabetes and malignancy.
Depressive Symptoms Not Tied to Amyloid Pathology in Adults with Normal Cognition
A study found depressive symptoms in older individuals with normal cognition were linked to amyloid pathology in APOE ε4 noncarriers but not carriers.
Medical Sisterhood: Polished and Powerful—Women Leading the Charge in Advocacy
Shadi Kourosh, MD, MPH, joins The Medical Sisterhood to discuss advocacy, mentorship, and the empowerment of women in medicine.
Tezepelumab Fails Study Endpoint of Reducing Moderate-to-Severe COPD Exacerbations
However, subgroup analyses may reveal a more pronounced effect in people with severe COPD.
Subcutaneous Amycretin Yields Promising Weight Loss in Phase 1b/2a Trial
Subcutaneous amycretin achieved up to a 22.0% weight loss over 36 weeks, with a consistent safety profile to other incretin-based therapies.
AGA Releases Clinical Practice Update on HBV Reactivation Prevention, Treatment
The updated clinical practice guideline addresses new research and clinical developments since the first iteration of the guideline was released in 2014.
Repurposing Medications for the Treatment of Patients with COPD
Joselyn Rojas-Quintero, MD, speaks about her team’s current research into COPD treatment on this issue of The Respiratory Report.
Poor Allergic Rhinitis Symptoms in Air Conditioning May Predict Greater Severity
A new study showed that experiencing worsened allergic rhinitis symptoms in air-conditioned environments may predict disease severity.
Skin of Color Savvy: News Update—SOCS Awards, My Best Winter Skin, & TORPEDO Program
The January 15, 2025 SOCS News Update highlights research ongoing/upcoming initiatives and awards, the My Best Winter Skin Campaign, and the TORPEDO program.
FDA Recalls First Aid Beauty Face Moisturizers Sold in US
This class 2 recall by FDA officials of almost 3000 First Aid Beauty brand face moisturizers resulted from deviation from Current Good Manufacturing Practice regulations.